Details for New Drug Application (NDA): 020791
✉ Email this page to a colleague
The generic ingredient in TESTODERM TTS is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 020791
Tradename: | TESTODERM TTS |
Applicant: | Alza |
Ingredient: | testosterone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020791
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM, EXTENDED RELEASE;TRANSDERMAL | Strength | 5MG/24HR | ||||
Approval Date: | Dec 18, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020791
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alza | TESTODERM TTS | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 020791-001 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Alza | TESTODERM TTS | testosterone | FILM, EXTENDED RELEASE;TRANSDERMAL | 020791-001 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription